Elizabeth A. Phelan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth A. Phelan has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin H. Balderson
Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA
2 shared publications - Monica M. Fujii
Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA 98101, USA
2 shared publications - Shelly L. Gray
Department of Pharmacy, School of Pharmacy University of Washington Seattle Washington USA
2 shared publications - Yuanjin Zhou
School of Social Work, The University of Texas at Austin, Austin, TX, USA
2 shared publications Alex Bohl
Department of Health Services, School of Public Health, University of Washington, Seattle, WA 98195, USA
1 shared publicationAmanda Kilcrease
Case Management Department, St. David’s North Austin Medical Center , Austin, Texas
1 shared publication
Latest Publications
- 2 May 2026
- Published by Oxford University Press (OUP) in The Gerontologist
- Vol. 66  (7)
A process model of engaging dementia care partners in fall risk management for health professionals
Background and Objectives: Family/friend care partners play an important role in managing fall risk for community-dwelling older people with dementia. Despite a lack of evidence-based strategies, health professionals have experiential knowledge in engaging care partners in fall risk management (FRM). The objective of this study was to develop a process model describing how experienced health professionals engage care partners in FRM for community-dwelling older people with dementia. Research Design and Methods: We used a qualitative descriptive approach and obtained semistructured interview data from 22 health professionals who had at least 5 years of direct clinical experience with community-dwelling older people with dementia. Interview data were examined by inductive/deductive hybrid thematic analysis. Results: The analysis of interview data suggested a novel process model whereby health professionals engage dementia care partners in FRM. The model mapped 22 activities into 6 discrete steps: (re)connect with care partners, determine when and how to engage care partners in FRM, collect information for fall risk assessment, make decisions and create a care plan for FRM, implement the FRM care plan, and review the care plan and determine if adjustments are needed. The process model also presents characteristics of the triadic care team and service organization and system-level factors that may influence how health professionals engage care partners in FRM. Discussion and Implications: The process model derived from this study can inform the development of interventions and training programs for health professionals to effectively engage care partners in managing fall risk for community-dwelling older people with dementia.
- 2 May 2026
- Published by Oxford University Press (OUP) in The Gerontologist
- Vol. 66  (7)
A process model of engaging dementia care partners in fall risk management for health professionals
Background and Objectives: Family/friend care partners play an important role in managing fall risk for community-dwelling older people with dementia. Despite a lack of evidence-based strategies, health professionals have experiential knowledge in engaging care partners in fall risk management (FRM). The objective of this study was to develop a process model describing how experienced health professionals engage care partners in FRM for community-dwelling older people with dementia. Research Design and Methods: We used a qualitative descriptive approach and obtained semistructured interview data from 22 health professionals who had at least 5 years of direct clinical experience with community-dwelling older people with dementia. Interview data were examined by inductive/deductive hybrid thematic analysis. Results: The analysis of interview data suggested a novel process model whereby health professionals engage dementia care partners in FRM. The model mapped 22 activities into 6 discrete steps: (re)connect with care partners, determine when and how to engage care partners in FRM, collect information for fall risk assessment, make decisions and create a care plan for FRM, implement the FRM care plan, and review the care plan and determine if adjustments are needed. The process model also presents characteristics of the triadic care team and service organization and system-level factors that may influence how health professionals engage care partners in FRM. Discussion and Implications: The process model derived from this study can inform the development of interventions and training programs for health professionals to effectively engage care partners in managing fall risk for community-dwelling older people with dementia.
- Open Access
- 22 October 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22  (11) , 1611
Deprescribing Central Nervous System-Active Medications Among Community-Dwelling Older Adults with Dementia in Primary Care: A Feasibility Study
Central nervous system (CNS)-active medications pose serious health risks for older adults with dementia but are nonetheless commonly used. Few deprescribing interventions have focused on people with dementia. We conducted a one-arm pilot study in six primary care practices of an integrated healthcare system between February and August 2023. The deprescribing intervention consisted of patient/care partner education and self-management materials and provider decision support. Participants were aged 60+ with diagnosed dementia and prescribed at least one CNS-active medication for three or more months of the six-month period prior to study start. We assessed feasibility and acceptability of the intervention and feasibility of ascertaining medication discontinuation and medically treated falls. The intervention was delivered to all (N = 114) eligible participants; their mean age was 80 ± 9 years; 72% were female and 13% non-White. Intervention acceptability, assessed by Weiner’s Acceptability of Intervention measure, was rated 3.5/5 (range 1–5; higher scores indicate higher acceptability). Among baseline antipsychotic users (N = 89), 39 (43.8%) had discontinued at follow-up. Among baseline tricyclic antidepressant users (N = 11), 6 (54.5%) had discontinued at follow-up. Among baseline skeletal muscle relaxant users (N = 3), 2 (66.7%) had discontinued at follow-up. Among baseline benzodiazepine users (N = 3), 1 (33.3%) had discontinued at follow-up. Among baseline opioid users (N = 13), 1 (7.7%) had discontinued at follow-up. Medically treated falls occurred among 22% at baseline vs. 21% at follow-up. The intervention is feasible and acceptable and may achieve meaningful reduction in CNS-active medication prescriptions. Findings support a controlled trial with sufficient power to assess effects on relevant clinical outcomes.
- 22 October 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22  (11) , 1611
Open AccessDeprescribing Central Nervous System-Active Medications Among Community-Dwelling Older Adults with Dementia in Primary Care: A Feasibility Study
Central nervous system (CNS)-active medications pose serious health risks for older adults with dementia but are nonetheless commonly used. Few deprescribing interventions have focused on people with dementia. We conducted a one-arm pilot study in six primary care practices of an integrated healthcare system between February and August 2023. The deprescribing intervention consisted of patient/care partner education and self-management materials and provider decision support. Participants were aged 60+ with diagnosed dementia and prescribed at least one CNS-active medication for three or more months of the six-month period prior to study start. We assessed feasibility and acceptability of the intervention and feasibility of ascertaining medication discontinuation and medically treated falls. The intervention was delivered to all (N = 114) eligible participants; their mean age was 80 ± 9 years; 72% were female and 13% non-White. Intervention acceptability, assessed by Weiner’s Acceptability of Intervention measure, was rated 3.5/5 (range 1–5; higher scores indicate higher acceptability). Among baseline antipsychotic users (N = 89), 39 (43.8%) had discontinued at follow-up. Among baseline tricyclic antidepressant users (N = 11), 6 (54.5%) had discontinued at follow-up. Among baseline skeletal muscle relaxant users (N = 3), 2 (66.7%) had discontinued at follow-up. Among baseline benzodiazepine users (N = 3), 1 (33.3%) had discontinued at follow-up. Among baseline opioid users (N = 13), 1 (7.7%) had discontinued at follow-up. Medically treated falls occurred among 22% at baseline vs. 21% at follow-up. The intervention is feasible and acceptable and may achieve meaningful reduction in CNS-active medication prescriptions. Findings support a controlled trial with sufficient power to assess effects on relevant clinical outcomes.
- Open Access
- 1 July 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7  (7) , e2424234
Reducing Central Nervous System–Active Medications to Prevent Falls and Injuries Among Older Adults
Importance: High-risk medications that contribute to adverse health outcomes are frequently prescribed to older adults. Deprescribing interventions reduce their use, but studies are often not designed to examine effects on patient-relevant health outcomes.Objective: To test the effect of a health system–embedded deprescribing intervention targeting older adults and their primary care clinicians for reducing the use of central nervous system–active drugs and preventing medically treated falls.Design, Setting, and Participants: In this cluster randomized, parallel-group, clinical trial, 18 primary care practices from an integrated health care delivery system in Washington state were recruited from April 1, 2021, to June 16, 2022, to participate, along with their eligible patients. Randomization occurred at the clinic level. Patients were community-dwelling adults aged 60 years or older, prescribed at least 1 medication from any of 5 targeted medication classes (opioids, sedative-hypnotics, skeletal muscle relaxants, tricyclic antidepressants, and first-generation antihistamines) for at least 3 consecutive months.Intervention: Patient education and clinician decision support. Control arm participants received usual care.Main Outcomes and Measures: The primary outcome was medically treated falls. Secondary outcomes included medication discontinuation, sustained medication discontinuation, and dose reduction of any and each target medication. Serious adverse drug withdrawal events involving opioids or sedative-hypnotics were the main safety outcome. Analyses were conducted using intent-to-treat analysis.Results: Among 2367 patient participants (mean [SD] age, 70.6 [7.6] years; 1488 women [63%]), the adjusted cumulative incidence rate of a first medically treated fall at 18 months was 0.33 (95% CI, 0.29-0.37) in the intervention group and 0.30 (95% CI, 0.27-0.34) in the usual care group (estimated adjusted hazard ratio, 1.11 (95% CI, 0.94-1.31) (P = .11). There were significant differences favoring the intervention group in discontinuation, sustained discontinuation, and dose reduction of tricyclic antidepressants at 6 months (discontinuation adjusted rate: intervention group, 0.23 [95% CI, 0.18-0.28] vs usual care group, 0.13 [95% CI, 0.09-0.17]; adjusted relative risk, 1.79 [95% CI, 1.29-2.50]; P = .001) and secondary time points (9, 12, and 15 months).Conclusions and Relevance: In this randomized clinical trial of a health system–embedded deprescribing intervention targeting community-dwelling older adults prescribed central nervous system–active medications and their primary care clinicians, the intervention was no more effective than usual care in reducing medically treated falls. For health systems that attend to deprescribing as part of routine clinical practice, additional interventions may confer modest benefits on prescribing without a measurable effect on clinical outcomes.Trial Registration: ClinicalTrials.gov Identifier: NCT05689554
- 1 July 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7  (7) , e2424234
Open AccessReducing Central Nervous System–Active Medications to Prevent Falls and Injuries Among Older Adults
Importance: High-risk medications that contribute to adverse health outcomes are frequently prescribed to older adults. Deprescribing interventions reduce their use, but studies are often not designed to examine effects on patient-relevant health outcomes.Objective: To test the effect of a health system–embedded deprescribing intervention targeting older adults and their primary care clinicians for reducing the use of central nervous system–active drugs and preventing medically treated falls.Design, Setting, and Participants: In this cluster randomized, parallel-group, clinical trial, 18 primary care practices from an integrated health care delivery system in Washington state were recruited from April 1, 2021, to June 16, 2022, to participate, along with their eligible patients. Randomization occurred at the clinic level. Patients were community-dwelling adults aged 60 years or older, prescribed at least 1 medication from any of 5 targeted medication classes (opioids, sedative-hypnotics, skeletal muscle relaxants, tricyclic antidepressants, and first-generation antihistamines) for at least 3 consecutive months.Intervention: Patient education and clinician decision support. Control arm participants received usual care.Main Outcomes and Measures: The primary outcome was medically treated falls. Secondary outcomes included medication discontinuation, sustained medication discontinuation, and dose reduction of any and each target medication. Serious adverse drug withdrawal events involving opioids or sedative-hypnotics were the main safety outcome. Analyses were conducted using intent-to-treat analysis.Results: Among 2367 patient participants (mean [SD] age, 70.6 [7.6] years; 1488 women [63%]), the adjusted cumulative incidence rate of a first medically treated fall at 18 months was 0.33 (95% CI, 0.29-0.37) in the intervention group and 0.30 (95% CI, 0.27-0.34) in the usual care group (estimated adjusted hazard ratio, 1.11 (95% CI, 0.94-1.31) (P = .11). There were significant differences favoring the intervention group in discontinuation, sustained discontinuation, and dose reduction of tricyclic antidepressants at 6 months (discontinuation adjusted rate: intervention group, 0.23 [95% CI, 0.18-0.28] vs usual care group, 0.13 [95% CI, 0.09-0.17]; adjusted relative risk, 1.79 [95% CI, 1.29-2.50]; P = .001) and secondary time points (9, 12, and 15 months).Conclusions and Relevance: In this randomized clinical trial of a health system–embedded deprescribing intervention targeting community-dwelling older adults prescribed central nervous system–active medications and their primary care clinicians, the intervention was no more effective than usual care in reducing medically treated falls. For health systems that attend to deprescribing as part of routine clinical practice, additional interventions may confer modest benefits on prescribing without a measurable effect on clinical outcomes.Trial Registration: ClinicalTrials.gov Identifier: NCT05689554
- Open Access
- 11 May 2023
- Published by Springer Nature in Trials
- Vol. 24  (1) , 1-15
A health-system-embedded deprescribing intervention targeting patients and providers to prevent falls in older adults (STOP-FALLS trial): study protocol for a pragmatic cluster-randomized controlled trial
Background: Central nervous system (CNS) active medications have been consistently linked to falls in older people. However, few randomized trials have evaluated whether CNS-active medication reduction reduces falls and fall-related injuries. The objective of the Reducing CNS-active Medications to Prevent Falls and Injuries in Older Adults (STOP-FALLS) trial is to test the effectiveness of a health-system-embedded deprescribing intervention focused on CNS-active medications on the incidence of medically treated falls among community-dwelling older adults. Methods: We will conduct a pragmatic, cluster-randomized, parallel-group, controlled clinical trial within Kaiser Permanente Washington to test the effectiveness of a 12-month deprescribing intervention consisting of (1) an educational brochure and self-care handouts mailed to older adults prescribed one or more CNS-active medications (aged 60 + : opioids, benzodiazepines and Z-drugs; aged 65 + : skeletal muscle relaxants, tricyclic antidepressants, and antihistamines) and (2) decision support for their primary health care providers. Outcomes are examined over 18–26 months post-intervention. The primary outcome is first incident (post-baseline) medically treated fall as determined from health plan data. Our sample size calculations ensure at least 80% power to detect a 20% reduction in the rate of medically treated falls for participants receiving care within the intervention (n = 9) versus usual care clinics (n = 9) assuming 18 months of follow-up. Secondary outcomes include medication discontinuation or dose reduction of any target medications. Safety outcomes include serious adverse drug withdrawal events, unintentional overdose, and death. We will also examine medication signetur fields for attempts to decrease medications. We will report factors affecting implementation of the intervention. Discussion: The STOP-FALLS trial will provide new information about whether a health-system-embedded deprescribing intervention that targets older participants and their primary care providers reduces medically treated falls and CNS-active medication use. Insights into factors affecting implementation will inform future research and healthcare organizations that may be interested in replicating the intervention. Trial registration: ClinicalTrial.gov NCT05689554. Registered on 18 January 2023, retrospectively registered.
- 11 May 2023
- Published by Springer Nature in Trials
- Vol. 24  (1) , 1-15
Open AccessA health-system-embedded deprescribing intervention targeting patients and providers to prevent falls in older adults (STOP-FALLS trial): study protocol for a pragmatic cluster-randomized controlled trial
Background: Central nervous system (CNS) active medications have been consistently linked to falls in older people. However, few randomized trials have evaluated whether CNS-active medication reduction reduces falls and fall-related injuries. The objective of the Reducing CNS-active Medications to Prevent Falls and Injuries in Older Adults (STOP-FALLS) trial is to test the effectiveness of a health-system-embedded deprescribing intervention focused on CNS-active medications on the incidence of medically treated falls among community-dwelling older adults. Methods: We will conduct a pragmatic, cluster-randomized, parallel-group, controlled clinical trial within Kaiser Permanente Washington to test the effectiveness of a 12-month deprescribing intervention consisting of (1) an educational brochure and self-care handouts mailed to older adults prescribed one or more CNS-active medications (aged 60 + : opioids, benzodiazepines and Z-drugs; aged 65 + : skeletal muscle relaxants, tricyclic antidepressants, and antihistamines) and (2) decision support for their primary health care providers. Outcomes are examined over 18–26 months post-intervention. The primary outcome is first incident (post-baseline) medically treated fall as determined from health plan data. Our sample size calculations ensure at least 80% power to detect a 20% reduction in the rate of medically treated falls for participants receiving care within the intervention (n = 9) versus usual care clinics (n = 9) assuming 18 months of follow-up. Secondary outcomes include medication discontinuation or dose reduction of any target medications. Safety outcomes include serious adverse drug withdrawal events, unintentional overdose, and death. We will also examine medication signetur fields for attempts to decrease medications. We will report factors affecting implementation of the intervention. Discussion: The STOP-FALLS trial will provide new information about whether a health-system-embedded deprescribing intervention that targets older participants and their primary care providers reduces medically treated falls and CNS-active medication use. Insights into factors affecting implementation will inform future research and healthcare organizations that may be interested in replicating the intervention. Trial registration: ClinicalTrial.gov NCT05689554. Registered on 18 January 2023, retrospectively registered.
- Open Access
- 17 December 2022
- Published by Springer Nature in BMC Geriatrics
- Vol. 22  (1) , 1-21
Development of a behavioural framework for dementia care partners’ fall risk management
Background: Although older adults living with dementia (OLWD) are at high risk for falls, few strategies that effectively reduce falls among OLWD have been identified. Dementia care partners (hereinafter referred to as “care partners”) may have a critical role in fall risk management (FRM). However, little is known about the ways care partners behave that may be relevant to FRM and how to effectively engage them in FRM. Methods: Semi-structured, in-depth interviews were conducted with 14 primary care partners (age: 48–87; 79% women; 50% spouses/partners; 64% completed college; 21% people of colour) of community-dwelling OLWD to examine their FRM behaviours, and their observations of behaviours adopted by other care partners who were secondary in the caring role. Results: The analysis of interview data suggested a novel behavioural framework that consisted of eight domains of FRM behaviours adopted across four stages. The domains of FRM behaviours were 1. functional mobility assistance, 2. assessing and addressing health conditions, 3. health promotion support, 4. safety supervision, 5. modification of the physical environment, 6. receiving, seeking, and coordinating care, 7. learning, and 8. self-adjustment. Four stages of FRM included 1. supporting before dementia onset, 2. preventing falls, 3. preparing to respond to falls, and 4. responding to falls. FRM behaviours varied by the care partners’ caring responsibilities. Primary care partners engaged in behaviours from all eight behavioural domains; they often provided functional mobility assistance, safety supervision, and modification of the physical environment for managing fall risk. They also adopted behaviours of assessing and addressing health conditions, health promotion support, and receiving, seeking and coordinating care without realizing their relevance to FRM. Secondary care partners were reported to assist in health promotion support, safety supervision, modification of the physical environment, and receiving, seeking, and coordinating care. Conclusions: The multi-domain and multi-stage framework derived from this study can inform the development of tools and interventions to effectively engage care partners in managing fall risk for community-dwelling OLWD.
- 17 December 2022
- Published by Springer Nature in BMC Geriatrics
- Vol. 22  (1) , 1-21
Open AccessDevelopment of a behavioural framework for dementia care partners’ fall risk management
Background: Although older adults living with dementia (OLWD) are at high risk for falls, few strategies that effectively reduce falls among OLWD have been identified. Dementia care partners (hereinafter referred to as “care partners”) may have a critical role in fall risk management (FRM). However, little is known about the ways care partners behave that may be relevant to FRM and how to effectively engage them in FRM. Methods: Semi-structured, in-depth interviews were conducted with 14 primary care partners (age: 48–87; 79% women; 50% spouses/partners; 64% completed college; 21% people of colour) of community-dwelling OLWD to examine their FRM behaviours, and their observations of behaviours adopted by other care partners who were secondary in the caring role. Results: The analysis of interview data suggested a novel behavioural framework that consisted of eight domains of FRM behaviours adopted across four stages. The domains of FRM behaviours were 1. functional mobility assistance, 2. assessing and addressing health conditions, 3. health promotion support, 4. safety supervision, 5. modification of the physical environment, 6. receiving, seeking, and coordinating care, 7. learning, and 8. self-adjustment. Four stages of FRM included 1. supporting before dementia onset, 2. preventing falls, 3. preparing to respond to falls, and 4. responding to falls. FRM behaviours varied by the care partners’ caring responsibilities. Primary care partners engaged in behaviours from all eight behavioural domains; they often provided functional mobility assistance, safety supervision, and modification of the physical environment for managing fall risk. They also adopted behaviours of assessing and addressing health conditions, health promotion support, and receiving, seeking and coordinating care without realizing their relevance to FRM. Secondary care partners were reported to assist in health promotion support, safety supervision, modification of the physical environment, and receiving, seeking, and coordinating care. Conclusions: The multi-domain and multi-stage framework derived from this study can inform the development of tools and interventions to effectively engage care partners in managing fall risk for community-dwelling OLWD.
- 1 March 2018
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 111, 149-158
Emergency information management needs and practices of older adults: A descriptive study
- 1 March 2018
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 111, 149-158
Emergency information management needs and practices of older adults: A descriptive study
- Top Cited Papers
- 1 March 2015
- Published by Elsevier in Medical Clinics of North America
- Vol. 99  (2) , 281-293
Assessment and Management of Fall Risk in Primary Care Settings
- 1 March 2015
- Published by Elsevier in Medical Clinics of North America
- Vol. 99  (2) , 281-293
Top Cited PapersAssessment and Management of Fall Risk in Primary Care Settings
- Top Cited PapersOpen Access
- 11 January 2012
- Published by American Medical Association (AMA) in JAMA
- Vol. 307  (2) , 165-172
Association of Incident Dementia With Hospitalizations
Claims-based, retrospective studies have long reported that dementia is associated with increased hospitalizations,1-9 but empirical data to elucidate this finding are few. Suboptimal management in the outpatient setting may be a contributing factor, as suggested by lower prescription drug costs and fewer office visits after diagnosis.4 Accomplishing adequate chronic disease management is more difficult in persons with dementia, which may lead to hospitalization for acute exacerbation of comorbid conditions.4,5 Nonelective hospitalization of older people, particularly those with dementia, is not a trivial event. Among older persons without dementia, hospitalization for serious illness is associated with subsequent cognitive decline,10 and frail elders, including those with dementia, are at increased risk of delirium, functional decline, and iatrogenic complications during an inpatient stay.11-13 Identifying conditions that precipitate hospitalization of elderly individuals with dementia could focus clinical priorities on secondary and tertiary prevention in the outpatient setting and improve health care for this vulnerable and increasing population. We used a unique longitudinal data set to determine whether dementia onset is associated with higher rates of or different reasons for hospitalization, particularly for ambulatory care–sensitive conditions (ACSCs), for which proactive outpatient care might prevent the need for a hospital stay.
- 11 January 2012
- Published by American Medical Association (AMA) in JAMA
- Vol. 307  (2) , 165-172
Top Cited PapersOpen AccessAssociation of Incident Dementia With Hospitalizations
Claims-based, retrospective studies have long reported that dementia is associated with increased hospitalizations,1-9 but empirical data to elucidate this finding are few. Suboptimal management in the outpatient setting may be a contributing factor, as suggested by lower prescription drug costs and fewer office visits after diagnosis.4 Accomplishing adequate chronic disease management is more difficult in persons with dementia, which may lead to hospitalization for acute exacerbation of comorbid conditions.4,5 Nonelective hospitalization of older people, particularly those with dementia, is not a trivial event. Among older persons without dementia, hospitalization for serious illness is associated with subsequent cognitive decline,10 and frail elders, including those with dementia, are at increased risk of delirium, functional decline, and iatrogenic complications during an inpatient stay.11-13 Identifying conditions that precipitate hospitalization of elderly individuals with dementia could focus clinical priorities on secondary and tertiary prevention in the outpatient setting and improve health care for this vulnerable and increasing population. We used a unique longitudinal data set to determine whether dementia onset is associated with higher rates of or different reasons for hospitalization, particularly for ambulatory care–sensitive conditions (ACSCs), for which proactive outpatient care might prevent the need for a hospital stay.
- Open Access
- 1 January 2011
- Published by Wiley in Journal of Aging Research
- Vol. 2011, 1-7
Older Adults' Perceptions of Clinical Fall Prevention Programs: A Qualitative Study
Objective. To investigate motivational factors and barriers to participating in fall risk assessment and management programs among diverse, low-income, community-dwelling older adults who had experienced a fall.Methods. Face-to-face interviews with 20 elderly who had accepted and 19 who had not accepted an invitation to an assessment by one of two fall prevention programs. Interviews covered healthy aging, core values, attributions/consequences of the fall, and barriers/benefits of fall prevention strategies and programs.Results. Joiners and nonjoiners of fall prevention programs were similar in their experience of loss associated with aging, core values they expressed, and emotional response to falling. One difference was that those who participated endorsed that they “needed” the program, while those who did not participate expressed a lack of need.Conclusions. Interventions targeted at a high-risk group need to address individual beliefs as well as structural and social factors (transportation issues, social networks) to enhance participation.
- 1 January 2011
- Published by Wiley in Journal of Aging Research
- Vol. 2011, 1-7
Open AccessOlder Adults' Perceptions of Clinical Fall Prevention Programs: A Qualitative Study
Objective. To investigate motivational factors and barriers to participating in fall risk assessment and management programs among diverse, low-income, community-dwelling older adults who had experienced a fall.Methods. Face-to-face interviews with 20 elderly who had accepted and 19 who had not accepted an invitation to an assessment by one of two fall prevention programs. Interviews covered healthy aging, core values, attributions/consequences of the fall, and barriers/benefits of fall prevention strategies and programs.Results. Joiners and nonjoiners of fall prevention programs were similar in their experience of loss associated with aging, core values they expressed, and emotional response to falling. One difference was that those who participated endorsed that they “needed” the program, while those who did not participate expressed a lack of need.Conclusions. Interventions targeted at a high-risk group need to address individual beliefs as well as structural and social factors (transportation issues, social networks) to enhance participation.